NCT07469059 Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy
| NCT ID | NCT07469059 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Erlangen-Nürnberg Medical School |
| Condition | Nephritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-18 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-09-18 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is the non-invasive visualization and quantification of renal microvascular dynamics in adult kidneys with proteinuria and/or active sediment.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Evidence of active urinary sediment and/or proteinuria \>1 g/g creatinine * Indication for kidney biopsy as part of study-independent diagnostics * Written informed consent Exclusion Criteria: * Known allergic disposition to SonoVue® * Contraindication to the use of SonoVue® * Pregnancy * Breastfeeding mothers
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07469059 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Nephritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07469059 currently recruiting?
Yes, NCT07469059 is actively recruiting participants. Contact the research team at ferdinand.knieling@uk-erlangen.de for enrollment information.
Where is the NCT07469059 trial being conducted?
This trial is being conducted at Erlangen, Germany.
Who is sponsoring the NCT07469059 clinical trial?
NCT07469059 is sponsored by University of Erlangen-Nürnberg Medical School. The trial plans to enroll 30 participants.